239 related articles for article (PubMed ID: 16121196)
1. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1.
Mizutani A; Wang L; Rajan H; Vig PJ; Alaynick WA; Thaler JP; Tsai CC
EMBO J; 2005 Sep; 24(18):3339-51. PubMed ID: 16121196
[TBL] [Abstract][Full Text] [Related]
2. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.
Lam YC; Bowman AB; Jafar-Nejad P; Lim J; Richman R; Fryer JD; Hyun ED; Duvick LA; Orr HT; Botas J; Zoghbi HY
Cell; 2006 Dec; 127(7):1335-47. PubMed ID: 17190598
[TBL] [Abstract][Full Text] [Related]
3. SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice.
Kang S; Hong S
Arch Ital Biol; 2010 Dec; 148(4):351-63. PubMed ID: 21308649
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals.
Servadio A; Koshy B; Armstrong D; Antalffy B; Orr HT; Zoghbi HY
Nat Genet; 1995 May; 10(1):94-8. PubMed ID: 7647801
[TBL] [Abstract][Full Text] [Related]
5. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors.
Tsai CC; Kao HY; Mitzutani A; Banayo E; Rajan H; McKeown M; Evans RM
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4047-52. PubMed ID: 15016912
[TBL] [Abstract][Full Text] [Related]
6. Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes.
Helmlinger D; Hardy S; Sasorith S; Klein F; Robert F; Weber C; Miguet L; Potier N; Van-Dorsselaer A; Wurtz JM; Mandel JL; Tora L; Devys D
Hum Mol Genet; 2004 Jun; 13(12):1257-65. PubMed ID: 15115762
[TBL] [Abstract][Full Text] [Related]
7. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1.
Matilla A; Koshy BT; Cummings CJ; Isobe T; Orr HT; Zoghbi HY
Nature; 1997 Oct; 389(6654):974-8. PubMed ID: 9353121
[TBL] [Abstract][Full Text] [Related]
8. RNA association and nucleocytoplasmic shuttling by ataxin-1.
Irwin S; Vandelft M; Pinchev D; Howell JL; Graczyk J; Orr HT; Truant R
J Cell Sci; 2005 Jan; 118(Pt 1):233-42. PubMed ID: 15615787
[TBL] [Abstract][Full Text] [Related]
9. The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.
Tsuda H; Jafar-Nejad H; Patel AJ; Sun Y; Chen HK; Rose MF; Venken KJ; Botas J; Orr HT; Bellen HJ; Zoghbi HY
Cell; 2005 Aug; 122(4):633-44. PubMed ID: 16122429
[TBL] [Abstract][Full Text] [Related]
10. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY
Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884
[TBL] [Abstract][Full Text] [Related]
11. The structure of the AXH domain of spinocerebellar ataxin-1.
Chen YW; Allen MD; Veprintsev DB; Löwe J; Bycroft M
J Biol Chem; 2004 Jan; 279(5):3758-65. PubMed ID: 14583607
[TBL] [Abstract][Full Text] [Related]
12. LAP2zeta binds BAF and suppresses LAP2beta-mediated transcriptional repression.
Shaklai S; Somech R; Gal-Yam EN; Deshet-Unger N; Moshitch-Moshkovitz S; Hirschberg K; Amariglio N; Simon AJ; Rechavi G
Eur J Cell Biol; 2008 May; 87(5):267-78. PubMed ID: 18403046
[TBL] [Abstract][Full Text] [Related]
13. Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice.
Vig PJ; Subramony SH; D'Souza DR; Wei J; Lopez ME
Brain Res Bull; 2006 May; 69(5):573-9. PubMed ID: 16647585
[TBL] [Abstract][Full Text] [Related]
14. Proteasome function is inhibited by polyglutamine-expanded ataxin-1, the SCA1 gene product.
Park Y; Hong S; Kim SJ; Kang S
Mol Cells; 2005 Feb; 19(1):23-30. PubMed ID: 15750336
[TBL] [Abstract][Full Text] [Related]
15. Hosting neurotoxicity in polyglutamine disease.
Liu N; Bonini NM
Cell; 2006 Dec; 127(7):1299-300. PubMed ID: 17190592
[TBL] [Abstract][Full Text] [Related]
16. A cell-based screen for modulators of ataxin-1 phosphorylation.
Kaytor MD; Byam CE; Tousey SK; Stevens SD; Zoghbi HY; Orr HT
Hum Mol Genet; 2005 Apr; 14(8):1095-105. PubMed ID: 15757972
[TBL] [Abstract][Full Text] [Related]
17. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
Xia H; Mao Q; Eliason SL; Harper SQ; Martins IH; Orr HT; Paulson HL; Yang L; Kotin RM; Davidson BL
Nat Med; 2004 Aug; 10(8):816-20. PubMed ID: 15235598
[TBL] [Abstract][Full Text] [Related]
18. A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation.
Kang AR; Park SH; Lee S; Choi DY; Kim KP; Song HK; Hong S; Kang S
Biochim Biophys Acta; 2015 May; 1854(5):356-64. PubMed ID: 25641559
[TBL] [Abstract][Full Text] [Related]
19. A role of helix 12 of the vitamin D receptor in SMRT corepressor interaction.
Kim JY; Son YL; Lee YC
Biochem Biophys Res Commun; 2009 Feb; 379(3):780-4. PubMed ID: 19133230
[TBL] [Abstract][Full Text] [Related]
20. Modeling and functional analysis of AEBP1, a transcriptional repressor.
Lyons PJ; Mattatall NR; Ro HS
Proteins; 2006 Jun; 63(4):1069-83. PubMed ID: 16538615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
